Conferences

The 12th Annual BioHealth Capital Region Week returns September 15–17, 2026, at US Pharmacopeia in Rockville, Maryland, bringing together leaders from industry, academia, government, investment, and entrepreneurship for three days of programming, networking, and regional collaboration. This year’s theme, “Growing the BioHealth Capital Region of Tomorrow,” reflects the work needed now to strengthen commercialization, expand access to capital, build new partnerships, and support the next generation of biohealth companies. As organizations across the ecosystem navigate a more uncertain funding environment, BHCR Week provides a place for the region to come together around shared priorities and future growth. The week includes the BioHealth Capital Region Forum, the Crab Trap Competition, and the BioHealth Capital Region Investment Conference.

KOREA LIFE SCIENCE WEEK 2026 is a premier B2B platform connecting the pharmaceutical, biotechnology, healthcare, and regenerative medicine industries in Korea. The exhibition features leading companies, innovative technologies, international conferences, and pre-arranged one-to-one partnering meetings, providing valuable opportunities for business development, investment, technology exchange, and global collaboration. Meet key decision-makers, discover emerging innovations, and build new partnerships in one of Asia's most dynamic life science markets.

Delegates from Venture Valuation and Biotechgate will attend the event.

The #CreativeDisruption Forum has partnered with Life Sciences Week West Midlands and Bruntwood SciTech to convene 130 leading investors, health innovation leaders, clinical decision-makers, and pioneering founders for a high-intensity, deal-making summit. This will be one of the leading investment and pitch events in the UK designed specifically for companies looking for Seed, Series A and Series B investment. Hosted at the newly launched No. 1 Birmingham Health Innovation Campus (BHIC)—the flagship hub of the West Midlands’ Life Sciences Opportunity Zone—this interactive forum bridges early-to-growth-stage life science companies directly with active venture capitalists, angel networks, and healthcare stakeholders.

RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partnering on September 25, 28-29. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions.

Delegates from Venture Valuation and Biotechgate will attend the event.

LSX Congress USA in Boston is where biotech companies at different stages of growth come to meet the investors and pharma partners who can help shape what comes next. From emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum, the event is built around the conversations that matter most. Get a 15% discount to LSX Congress USA when signing up by using the promo code: VV15. Register here »

Delegates from Venture Valuation and Biotechgate will attend the event.

A global, multi-time zone online Forum offers an essential half-day of insight and debate for those working at the intersection of drug discovery, innovation and investment.

BIOSPAIN is one of the largest biotech events organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 30% of our delegates came from outside of Spain. Also, of the 287 exhibitors, 32% were international. This year, BIOSPAIN will be held in Bilbao, one of the main biotech cluster in Spain and One of Spain’s most avant-garde cities. The event will take place in Pavillion 2, Bilbao Exhibition Cente, located in Barakaldo, less then 20 minutes from downtown Bilbao, it is one of the most modern and largest trade-show complexes in Europe. Get a 10% discount to BIOSPAIN by using the promo code: VENTUREVALU10.

Delegates from Venture Valuation and Biotechgate will attend the event.

Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech and healthtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 19 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. The conference has a broad focus within biotech, healthtech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial

Delegates from Venture Valuation and Biotechgate will attend the event.

LabTech is the premier event for professionals navigating the rapidly evolving research and laboratory ecosystem — with a sharp focus on life science, pharmaceutical, biotech, and clinical R&D industries. Bringing together cutting-edge technologies, forward-thinking strategies, and leading expert voices, LabTech defines what the next generation of research, development, and manufacturing looks like. From AI-driven analytics to fully connected lab operations, discover how digitalization and automation are fundamentally reshaping the modern laboratory — across early discovery, translational research, and clinical development alike.

CPHI Milan 2026 is the world’s largest pharmaceutical trade fair, that will bringing the global pharma community together at Fiera Milano from October 06–08, 2026. In this 35th year of innovation, the CPHI Worldwide Milan 2026 will have over 62,000 visitors, and 2,400 exhibitors, from 166+ countries.

Delegates from Venture Valuation and Biotechgate will attend the event.

Returning for its 26th Annual Edition, this established global bio-pharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Leading industry figures will contribute their insights through a series of panel discussions covering the broader market outlook, as well as innovation across different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage, and public companies with leading investors, analysts, money managers, and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners.

Delegates from Venture Valuation and Biotechgate will attend the event.

BioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering. This year marks the 40th Anniversary since the first edition held in 1986, making BioJapan the world’s longest-running biotech exhibition. Along with its two co-located shows —Regenerative Medicine JAPAN, which accelerates R&D and commercialization in regenerative medicine, and healthTECH JAPAN, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences — BioJapan continues to drive innovation and collaboration in the industry.

Delegates from Venture Valuation and Biotechgate will attend the event.

AusBiotech Invest is a core pillar of Australia’s Biggest Week in Biotech, a curated capital convening designed to strengthen the investment and capital environment around Australian life sciences. More than a company showcase or investor-matching exercise, this AusBiotech Invest event will on the Gold Coast will bring together active investors, capital partners and a specially selected high potential companies to explore investment opportunities, market insights, syndication pathways and the broader conditions required to fund and scale high-potential Australian innovation. The program is being shaped through ongoing engagement with investors and capital partners to ensure it delivers meaningful opportunities for discussion, connection and investment consideration.

Delegates from Venture Valuation and Biotechgate will attend the event.

The AusBiotech International Conference is Australia’s largest biotechnology conference and part of Australia’s Biggest Week in Biotech, connecting local expertise with Australian and international partners to accelerate innovation and impact. Join us at the Gold Coast Convention & Exhibition Centre, Queensland, from 21 to 23 October, 2026. This October, AusBiotech International Conference will be presented alongside the AusMedtech Conference, connecting local expertise with Australian and international partners to accelerate innovation and impact. Your International Conference registration will include access to all AusMedtech events.

Delegates from Venture Valuation and Biotechgate will attend the event.

BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.

Delegates from Venture Valuation and Biotechgate will attend the event.

Through expert-led discussions and networking, attendees will gain insights into the impact of AI and emerging technologies, access to early-stage capital, regulatory developments, and the strategies and partnerships needed to accelerate the path from discovery to patient impact.

Bringing together the healthcare ecosystems of France, Germany, and Switzerland, the Health Innovation Nexus is the leading trinational event for innovation and collaboration in the Upper Rhine region. It connects companies, hospitals, universities, research organizations, public authorities, and innovation stakeholders to exchange ideas, spark partnerships, and shape the future of healthcare. Discussions will focus on emerging technologies, health data, European health policy, resilience, supply chains, and cross-border cooperation. A dedicated B2B matchmaking platform will enable participants to build valuable connections and launch new collaborative projects across borders.

Delegates from Venture Valuation and Biotechgate will attend the event.

BIO-Europe, Europe's premier biopharma partnering event, is heading to Cologne, Germany on November 9-11, 2026.

Delegates from Venture Valuation and Biotechgate will attend the event.

'LSX Investival Showcase Europe brings together biotech innovators, medtech pioneers, healthcare investors and corporate strategics from across Europe and beyond, creating a dynamic environment for investment discussions, partnering opportunities and business development. For life science companies, the Investival Showcase offers a valuable opportunity to build visibility with the European and global market, pitch to active investors and build new connections through organised partnering and networking opportunities. Taking place on the first day of London Life Science Week, it's growing in size and scale. It's the first and biggest public event of the week, open to the wider life science community, and offers full partnering facilities to all attendees. Get a 15% discount to LSX Investival Showcase Europe by using the promo code: VENTUREVALUATION15.

Delegates from Venture Valuation and Biotechgate will attend the event.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Delegates from Venture Valuation and Biotechgate will attend the event.

The RESI Conference will be held on January 11-12 at the San Francisco Marriott Marquis, featuring two days in-person event followed by three days (January 13, 18 & 19) of online partnership activities. Previous RESI JPM conferences have drawn over a thousand attendees, including more than 600 early-stage life science investors, innovators, and industry experts. This RESI is held concurrently with JP Morgan Healthcare Week. As the largest and most comprehensive healthcare investment symposium, it attracts thousands of life science professionals globally.

Delegates from Venture Valuation and Biotechgate will attend the event.

Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives.

Delegates from Venture Valuation and Biotechgate will attend the event.

The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

Set in one of Europe's leading life sciences hubs, the Basel conference explores how drug discovery can scale through advanced technologies, European investment, strategic partnerships, and cross-border collaboration.

The Swiss Biotech Day conference celebrates the power of international collaboration, driving innovation, partnerships and global impact. Since 2021, the Swiss Biotech Day has grown by an average of 35% every year, establishing itself as one of the world’s premier biotechnology conferences. It brings together life sciences leaders from across the globe to spark collaboration, innovation and meaningful partnerships. In 2026, the event welcomed more than 3,500 participants from 58 countries, including 31 international delegations, a testament to its global reach and impact. It was by far the biggest and most international edition of the Swiss Biotech Day ever. Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.

Delegates from Venture Valuation and Biotechgate will attend the event.